ResearcherTongji UniversityNo recent work listed
Yongkang Liu
Matched on ORCID iD 0000-0003-0641-9518; OpenAlex author ID A5101959288. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper
Papers 6
- Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. Last author DOI 10.3892/mmr.2023.12943↗
- Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2147/ott.s296816↗
- N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. Co-author DOI 10.7150/ijbs.60115↗
- Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging. Co-author DOI 10.1016/j.ebiom.2018.03.008↗
- Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Progn… Co-author DOI 10.1159/000495228↗
- VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model. Co-author PMID 23393331↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bing Ni · 3 shared papers, 2018–2023 · strength 0.48
- Paper Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. DOI 10.3892/mmr.2023.12943↗
- Paper N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. DOI 10.7150/ijbs.60115↗
- Paper Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and… DOI 10.1159/000495228↗
- Huaizhi Wang · 3 shared papers, 2018–2023 · strength 0.48
- Paper Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. DOI 10.3892/mmr.2023.12943↗
- Paper N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. DOI 10.7150/ijbs.60115↗
- Paper Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and… DOI 10.1159/000495228↗
- Wenhua Li · 2 shared papers, 2018–2023 · strength 0.31
- Paper Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. DOI 10.3892/mmr.2023.12943↗
- Paper Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and… DOI 10.1159/000495228↗
- Zhongqiu Wang · 3 shared papers, 2013–2021 · strength 0.24
- Paper Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. DOI 10.2147/ott.s296816↗
- Paper Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging. DOI 10.1016/j.ebiom.2018.03.008↗
- Paper VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model. PMID 23393331↗
- Jian Li · 1 shared paper, 2023 · strength 0.24
- Jian Li · 1 shared paper, 2021 · strength 0.17
- Cheng Wang · 1 shared paper, 2021 · strength 0.13
- Xin Chen · 1 shared paper, 2021 · strength 0.13
- Xiao Chen · 1 shared paper, 2021 · strength 0.13
- Jianhua Wang · 1 shared paper, 2021 · strength 0.13
- Lina Song · 1 shared paper, 2018 · strength 0.08
- Xiao Chen · 1 shared paper, 2018 · strength 0.08
- Yunchao Wang · 1 shared paper, 2018 · strength 0.07
- Jiayun Ge · 1 shared paper, 2018 · strength 0.07
- Jian Li · 1 shared paper, 2018 · strength 0.07
- Huan Qin · 1 shared paper, 2018 · strength 0.07
- Zhiping Zhao · 1 shared paper, 2018 · strength 0.07
- Songsong Liu · 1 shared paper, 2018 · strength 0.07
- Ming-Min Tong · 1 shared paper, 2013 · strength 0.03
- Yuzhen Shi · 1 shared paper, 2013 · strength 0.03
- Robert M. Hoffman · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.